FDA Fast-Tracks Psychedelic Drug Approvals to Combat Mental Health Crisis FDA Fast-Tracks Psychedelic Drug Approvals to Combat Mental Health Crisis WASHINGTON — In a decisive move to expand the arsenal of psychiatric medicine, the U.S. Food and Drug Administration (FDA) is accelerating the review process for a new wave of psychedelic therapies aimed at treating … Read more
Political Patronage or Professional Expertise? The Controversy Behind New NIH Advisory Council Appointments A quiet appointment at the National Institutes of Health (NIH) has ignited a fierce debate over the intersection of scientific integrity and political loyalty. Kristine Blanche, a physician specializing in integrative medicine and the wife of acting Attorney General Todd Blanche, has … Read more
AI as a ‘Denial Device’: Washington Hospitals Sound Alarm Over Medicare WISeR Model Delays Critical healthcare bottlenecks are paralyzing Washington state hospitals, where Medicare patients are facing wait times for essential procedures that have surged to two to four times their previous durations. The crisis centers on the implementation of the Wasteful and Inappropriate Service … Read more
RFK Jr. Vaccine Stance Shifts: Health Secretary Now Urges MMR and Funds New Shots WASHINGTON — In a stunning reversal that has sent shockwaves through the public health community, Health Secretary Robert F. Kennedy Jr. appears to have abandoned his long-held skepticism regarding immunization. For years, Kennedy was a prominent voice claiming that no vaccines … Read more
Merck’s Potential $5 HIV Prevention Pill Offers Hope for Global Access A groundbreaking analysis reveals that a novel HIV prevention pill, currently in development by Merck, could be manufactured for as little as $5 per patient annually. This dramatically low cost has ignited optimism among global health advocates, who believe it could pave the way … Read more
Trump Administration Imposes Tariffs on Imported Drugs, Forging Deals for Domestic Production Washington D.C. – In a move poised to reshape the pharmaceutical landscape, the Trump administration has enacted tariffs of up to 100% on certain brand-name drugs imported into the United States. The policy, announced this week, isn’t a blanket imposition, however, and hinges … Read more
The biopharmaceutical landscape is in constant flux, and leadership transitions often signal pivotal shifts in strategy and innovation. Today, Proxygen, a rapidly advancing biotechnology company, announced the appointment of Chiara Conti as its new Chief Scientific Officer. This strategic hire underscores Proxygen’s commitment to cutting-edge research and development as it navigates the complex world of … Read more
White House Proposes Over 12% Cut to Health and Human Services in 2027 Budget Washington D.C. – The Biden administration unveiled its proposed federal budget for 2027 on Friday, outlining plans to reduce funding for the Department of Health and Human Services (HHS) by more than 12%. This significant proposed decrease signals a potential shift … Read more
White House Proposes $5 Billion NIH Budget Cut, Institute Restructuring Washington D.C. – In a move poised to ignite fierce debate, the White House has unveiled its fiscal year 2027 budget request, proposing a significant $5 billion reduction in funding for the National Institutes of Health (NIH). The plan, released Friday, also calls for a … Read more
Potential 100% Tariff on Imported Prescription Drugs Sparks Concern WASHINGTON – The administration is reportedly preparing an executive order that could impose a substantial 100% tariff on all prescription medications and their key ingredients sourced from overseas. This dramatic measure, if enacted, threatens to significantly increase the cost of life-saving drugs for Americans and disrupt … Read more